All lobbying filings
Ballard Partners
Ballard Partners filed a Q3 report for Rio Biopharmaceuticals, Inc. on October 17, 2025, reporting $150,000 in lobbying income.
Lobbying for Rio Biopharmaceuticals, Inc. · Pharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Income
$150,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbyists on this filing
1
-
ALISON ANWAYPreviously held: LA to Senator Pat Roberts 2006-2010
Government bodies contacted
6
Lobbying activity
1
Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.